CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RYTM

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q1 '27
RYTMPhase 3

Setmelanotide Phase 3 Est. Readout

Setmelanotide
Q1 2027~QSTALE
CT.gov
00%
Oct '26
RYTMPhase 2

Setmelanotide Phase 2 Est. Readout

Setmelanotide
Oct 2026~
CT.gov
00%
Development History
Sep '26
RYTMPhase 3

Setmelanotide Phase 3 Est. Readout

Setmelanotide
Sep 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Genetic Obesity

View Full Landscape
Drug Information

Target Indication

Genetic Obesity

Clinical Trial

NCT03013543

Last updated: 12/29/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.